American CryoStem Corporation Email Format
Biotechnology ResearchNew Jersey, United States11-50 Employees
American CryoStem Corporation is a clinical-stage biotechnology company that focuses on autologous regenerative therapies derived from adipose tissue and adipose-derived mesenchymal stem cells. Its core platform enables collection, processing, cryobanking, and delivery to point-of-care, allowing for on-demand manufacturing of autologous cell samples for personalized treatments across a lifetime. The company targets conditions with significant unmet medical needs, currently prioritizing research into post-concussion syndrome and Long COVID/Post-Acute Sequelae of SARS-CoV-2, with clinical trials listed for these areas.